# Progression Delaying Effect of Escitalopram in Alzheimer's Disease

> **NCT00702780** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 74 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** escitalopram
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00702780
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2014-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702780, "Progression Delaying Effect of Escitalopram in Alzheimer's Disease". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00702780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*